antepartum assessment

63

description

antepartum assessment. Fetal movements Fetal breathing movements Contraction stress test Non-stress test Biophysical profile Amnionic fluid volume Umbilical Artery Doppler Velocimetry Current recommendations Significance of fetal testing. contents. - PowerPoint PPT Presentation

Transcript of antepartum assessment

Page 1: antepartum  assessment
Page 2: antepartum  assessment

ANTEPARTUM ASSESSMENT

Page 3: antepartum  assessment

CONTENTS

I. Fetal movementsII. Fetal breathing movementsIII. Contraction stress testIV. Non-stress testV. Biophysical profileVI. Amnionic fluid volumeVII. Umbilical Artery Doppler Velocimetry Current recommendationsSignificance of fetal testing

Page 4: antepartum  assessment

INTRODUCTION

-In the 1st William obstetric edition 1903: FHR > 160 b/m or < 100 b/m is dangerous

-Now the fetus is considered as a 2nd patient and exposed to serious morbidity and

mortality > his mother -Fetal testing is now extended to the

embryonic life: e.g. Embryonic HR may predict pregnancy

outcome

Page 5: antepartum  assessment

Our goal is to prevent fetal deathFetal death within 7 days of a normal test is very rareIn most tests:

+ve predictive value (true +ve) = 99.8%

--ve predictive value of abnormal tests(true –ve = )10 – 40%

Page 6: antepartum  assessment

FETAL MOVEMENTS

Page 7: antepartum  assessment

-FMs starts at 7th week -At 8th week FMs are never

absent > 13 minutes -At 20 – 30 weeks organization

of FMs ( rest - activity cycles) -In the 3rd trimester until 36 weeks

maturation of FMs > -36 weeks behavioral states

Page 8: antepartum  assessment

BEHAVIORAL STATES

FHR FMs1F quite sleep vvvvvv no2F active sleep VVVVV I3F VVVVV no4F awake state VVVVV IIIIII

+ FHR accelerationsThe presence of F3 is debateContinuous eye movements are present in: 2F, 3F, 4F

Page 9: antepartum  assessment

At 38 weeks 75% of the time 1F&2FStudy:Urinary bladder ↑ in 1F and ↓ in 2FSleep – awake cycles :

Sleep 20 - 75 minutes Mean = 23 minutes

Maternal perception of FMs is described as: weak - strong - rolling

Page 10: antepartum  assessment

FMs is α to AFV:As GA ↑ > 20 weeks

weak FMs ↓ vigorous FMs ↑

>32 weeks strong FMs ↓ due to: ↓ AFV ↓ space

Normal FMs : = 4 – 10 FMs / 12 hours

Page 11: antepartum  assessment

In 1973 ↓ FM precede fetal deathMethods of measuring FMs:

Tocodynamometer U/S Maternal perception

Study :Maternal perception = 80% of FMs by U/SStudy:

> -36 weeks, maternal perception = 16% -Longer FMs > 20 seconds are better felt

Page 12: antepartum  assessment

Optimal number and duration of FMs: Not defined

Study: Normal FMs = 10 FMs/2 hours

Study : FM/1 hour is good if ≥ previous count

Patient complaint of ↓ FMs in the 3rd T:

Not uncommon = 7% same pregnancy outcome Evaluate & reassure

Page 13: antepartum  assessment

NST is indicated if: Abnormal fetal growth by U/S Abnormal Doppler

Study: Mean duration to record 10 FMs

= 2.7 hours of counting/dayStudy:

Asking mothers about FMs each visit = counting FMs

Page 14: antepartum  assessment

II - BREATHING MOVEMENTS

Page 15: antepartum  assessment

In 1972 inward and outward flows of tracheal fluid in sheep = BMsBMs differ from FMs:

Paradoxical = inspiration collapse expiration distend

Not continuousMay be coughing to expel AF debris Essential for fetal development

Page 16: antepartum  assessment

Types of BMs: Gasps/sighs = 1 - 4/minute Irregular bursts = up to 240c/mAs GA ↑ BMs rate ↓ & volume ↑

At 33 – 36 weeks = lung maturation30 - 40 weeks diurnal variation:

↑ after meals ↓ at night

Page 17: antepartum  assessment

If BMs are not seen extend U/S evaluation for up to 2 hours before diagnosis of absent BMsFactors affecting BMs:

Hypoxia Sound Hypoglycemia Cigarette

Labor FHR Impending PTL GA

Amniocentesis

Page 18: antepartum  assessment

BMs as a marker of fetal wellbeing:Unfulfilled because multiple factors itaffect it, but it is included in BPP withOther indices

Page 19: antepartum  assessment

IV - CONTRACTION STRESS TEST

Page 20: antepartum  assessment

Basis:Uterine contractions

↑ amnionic fluid P collapse of uterine vessels

isolation of intervillous space transient ↓ O2 exchange

If uteroplacental pathology is present late decelerations

Page 21: antepartum  assessment

CST is present since 1972Late decelerations:Start at/or beyond the acme of uterine contractionDisadvantages:Require 1 ½ hours

Page 22: antepartum  assessment

Method:Oxytocin 0.5 mIU/minute by infusion pumpdoubled /20 minutes 3 contractions in

10 minutes duration of each ≥ 40 secondsNipple stimulation:

1 nipple is rubbed through her clothes for 2 minutes or until contractions start, restart

After 5 minutes 3 contractions in 10 minAdvantages: ↓ time and costMay hyperstimulation with mild FD

Page 23: antepartum  assessment

CRITERIA FOR INTERPRETATION OF CST

Negative: No LD or significant VD Positive: LD + 50% of contractions

even if contractions are < 10/m

Equivocal-suspicious : Intermittent LD Significant VD

Equivocal-hyperactive : LD + > 3 contractions/10m Contraction > 90 seconds

Unsatisfactory : < 3 contractions /10m Uninterruptable tracing

Page 24: antepartum  assessment

VI – NONSTRESS TEST

Page 25: antepartum  assessment

1975Basis:FMs FHR accelerations = good signEquipments:

Doppler Maternal perception of FMs

Differ from CST and much easierUsed to discriminate false +ve CSTUsed in BPP

Page 26: antepartum  assessment

Physiology:Beat to beat variability > 5 b/m + FHR accelerations = good autonomic functionMost common causes of no accelerations:

Fetal sleep Drugs

As GA ↑ ↑ FMs + ↑ FHR accelerations25 – 28 weeks accelerations are

70% 15 b/m for 15 seconds90% 10 b/m for 10 seconds

<32 weeks use 10 b/m for 10 seconds

Page 27: antepartum  assessment

Normal NST:Vary in number, amplitude & durationof acceleration

=≥2 accelerations that peak at ≥ 15 b/mfor ≥ 15 seconds in 20 minutes ± FM

1 acceleration is enough by someIf no accelerations extend examination to 40-75-80-120 minutes before diagnosis of nonreactive NST

Page 28: antepartum  assessment

No accelerations = not bad fetusFalse +ve NST ≥ 90%Disadvantages of NST:

↑cost Irreducibility

Computerized analysis: ↓ cost Reliable objective

Page 29: antepartum  assessment

Abnormal NST: -Silent oscillatory pattern =

ominous = beat - to - beat variability < 5

b/m + no accelerations

-Terminal cardiogram: Both + LD

= uteroplacental insufficiency

Page 30: antepartum  assessment

Abnormal NST is associated with:FGR 75%Oligohydramnios 80%Acidosis 40%Meconium 30%Placental infarction 93%Study:Nonreactive NST for ≥ 90 min is associated with ↑ perinatal pathology in 93%

Page 31: antepartum  assessment

Interval between tests:1/week

2/week, 1/day, > 1/day in: Postterm Type 1 DM FGR PIH

Page 32: antepartum  assessment

Decelerations:Normally present in ½ to 2/3 of fetuses

Variable decelerations : Not ominous if nonrepetitive and brief

<30 secondsRepetitive VD ≥ 3 /20 minutes even if mild are associated with ↑ CS for FDDecelerations ≥ 1 min bad prognosis

Page 33: antepartum  assessment

Study: -Addition of NST to AFV 75% CS for

FD in cases of ↑ VD + ↓ AFV -FD in labor + normal AFV is increased

in patients with VDFalse - normal NSTs:

= fetal death within 7 days of a normal NST

Page 34: antepartum  assessment

Mean interval between testing and death: = 4 days Range: = 1 - 7 daysMost common indication of NST:

= posttermMost common autopsy findings:

Meconium Abnormal umbilical cord

Page 35: antepartum  assessment

=Acute asphyxial insult =NST is inadequate to preclude such an acute asphyxial events

Other causes: Fetomaternal Hg Infection Abruptoplacenta Congenital anomalies Abnormal cord insertion

Page 36: antepartum  assessment

Acoustic Stimulation Tests:Artificial larynx acoustic stimulationto ↑ accelerationMethod:

External sound for 1 – 2 secondsRepeat 1 – 3 times for up to 3 secondsStill under evaluation

Page 37: antepartum  assessment

VII – BIOPHYSICAL PROFILE

Page 38: antepartum  assessment

Manning & colleagues 19805 variables to ↓ false +ve

↓false –ve resultsEquipments:

Doppler Real time U/S

Duration of testing : 1/2 – 1 hour

Page 39: antepartum  assessment

2 0NST ≥ 2 accelerations < 2

( ≥15 b/m for ≥15 sec in 40 minutes)FBMs ≥ 1 ≥ 30 sec in 30 m < 30 secFMs ≥ 3 in 30m < 3

F Tone ≥ 1-- AFV > 2 cm ≥ 2 cm

( largest single vertical pocket )

Page 40: antepartum  assessment

Fetal tone = flexion and extension of one limb or opening or closing hand

NST is not required if the 4 variables are normal

AFI if the largest vertical pocket is ≥ 2 cm should be evaluated

BPP = 6 is equivocal and poor predictor of abnormal outcome

BPP = < 6 is progressively more accurate predictor of abnormal outcome

Page 41: antepartum  assessment

Study:BPP followed by cordocentesis for pH:

-20% of fetuses are FGR -80% of fetuses have alloimmune

hemolytic anemiaBPP = 0 is associated with acidemiaBPP = 8 - 10 is associated with

normal pH

Page 42: antepartum  assessment

Study:BPP+cordiocentasis in DMno benefitStudy:

BPP+cordiocentasis in GRno benefitThe morbidity and mortality in GR depend on GA & wt not BPP results Modified BPP( abbreviated BPP 1989):

=vibroacoustic NST + AFV X 2/weekDuration of testing = 10 minutes

Page 43: antepartum  assessment

If AFV is < 5 do complete BPP or CSTCST ↑CS for false abnormal resultsAcceptable by ACOGFalse –ve rate = 0.8 : 1000False +ve rate = 1.5 : 1000Study:

Excellent method with no unexpected FD

Page 44: antepartum  assessment

MODIFIED BPP MANAGEMENT

BPP = 10: Repeat 1/w

2/w in DM & posttermBPP = 8 -10 + normal AFV :

RepeatBPP = 8 -10 + ↓ AFV :

Chronic fetal asphyxia suspected Deliver

Page 45: antepartum  assessment

BPP = 6: Possible fetal asphyxia

If > 36 weeks + normal AFV + favorable cervix deliver

If < 36 weeks + normal AFV repeat:

if ≥ 6 deliver if > 6 repeat

If + ↓ AFV deliver

Page 46: antepartum  assessment

BPP = 4: Probable fetal asphyxia

repeat same day if ≥ 6 deliver

BPP = 0 - 2: Almost certain fetal asphyxia

deliver

Page 47: antepartum  assessment

VIII – AMNIONIC FLUID VOLUME

Page 48: antepartum  assessment

Basis:Uteroplacental insufficiency

↓ fetal renal blood flow ↓ urine production

↓ AFVMethods:

AVI Largest vertical pocket 2 x 2 cm pocket

Page 49: antepartum  assessment

Study: AFI < 5 cm

↑CS for FD ↑low 5 minutes Apgar score

↑perinatal morbidity & mortalityStudy:

20% of fetuses have AFI < 5 cm AFI = poor diagnostic testStudy:Same results in severe preeclampsia

Page 50: antepartum  assessment

Study:Nonintervention to permit spontaneous

VD in fetuses with AFI < 5 same pregnancy outcome as

induction of labor

Page 51: antepartum  assessment

IX – UMBILICAL ARTERYDOPPLER VELOCIMETRY

Page 52: antepartum  assessment

Basis:To assess blood flow by characterizingdownstream impedanceUterine artery S/D ratio:Most commonly useded, abnormal if :

- ↑95th percentile for GA - Diastolic flow is :

Absent (perinatal mortality = 10%)Reversed (perinatal mortality = 33%)

Page 53: antepartum  assessment

Both absent and reversed diastolic flow are associated with IUGRStudy:NST = DopplerStudy:No benefit other than suggesting GRStudy:No benefit in other diseases as: PIH ,DM, lupus anticoagulant, postterm

Page 54: antepartum  assessment

Middle cerebral artery S/D ratio:May reflect fetal compromise

Based on brain sparing theory : =uteroplacental insufficiency

↑ blood flow + ↓ impedanceStudy:No significant differenceStill under evaluation

Page 55: antepartum  assessment

CURRENT RECOMMENDATIONS

Page 56: antepartum  assessment

No agreement for the best testAll tests have different end points that are considered according to the clinical situationWhen to start?

Most important considerations in decidingwhen to start:

Prognosis of neonatal survival Severity of maternal disease

In high risk patients at 32 – 34 weeks In more severe cases at 26 – 28 weeks

Page 57: antepartum  assessment

Frequency of testing: ≥ 1/weekIn parkland hospital:All high risk patients are admittedNST 2 – 3/week for admitted cases If FHR accelerations + Deceleration No need for delivery If ↓ FMs or ↓ AFV in 3rd T Admission in labor suit

Page 58: antepartum  assessment

According to results of NST the patient is:

Discharged Transformed to high risk ward Delivered

Fetal deaths in high risk patients are lowMost fetal deaths are in low risk patients due to unpreventable events as:

Placental abruptions Cord accidents

Page 59: antepartum  assessment

SIGNIFICANCE OF TESTING

Page 60: antepartum  assessment

Does it make any difference?Fetal surveillance in 1970s = < 1%

in 1980s = 15%Fetal death rate ↓ in high risk testedpatients # untested patientsStudy:NSTs/CSTs are not recommended because of ↑ cost

Page 61: antepartum  assessment

Study:No benefit of testing forms of care likely to be ineffective or harmfulCan we identify fetal asphyxia early enough to prevent brain damage?Study:

Abnormal NST is associated with ↓cognition # Doppler = by the time fetal compromise is diagnosed ,

brain damage is already sustained

Page 62: antepartum  assessment

Study:CP in high risk patients managed by BPP = 1.3 : 1000 live birth

# 4.7 : 1000 in controlsIn a prior report:CP is associated with ↓ BPP scores

=identification is too late

Page 63: antepartum  assessment

SUMMERY

In the last 2 decades: -Methods are continuously evolving

= dissatisfaction -Wide range of normal variables:

How many accelerations–FMs–FBMs duration and frequency of testing

-Abnormal results are seldom reliable = forecast fetal wellness rather

than illness